62 related articles for article (PubMed ID: 20381102)
21. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
Svatek RS; Sims R; Anderson JK; Abdel-Aziz K; Cadeddu JA
Urology; 2006 Mar; 67(3):508-12. PubMed ID: 16504265
[TBL] [Abstract][Full Text] [Related]
22. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation for renal tumors: our experience.
Hiraoka K; Kawauchi A; Nakamura T; Soh J; Mikami K; Miki T
Int J Urol; 2009 Nov; 16(11):869-73. PubMed ID: 19735313
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.
Tan YK; Best SL; Olweny E; Park S; Trimmer C; Cadeddu JA
Urology; 2012 Apr; 79(4):827-30. PubMed ID: 22309782
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.
Cho YK; Rhim H; Ahn YS; Kim MY; Lim HK
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S269-74. PubMed ID: 16632687
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
Park BK; Kim CK
Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
Jiménez E; Zurera L; Espejo JJ; Requena MJ; Campos P; Rodríguez de Tembleque L; Canis M
Arch Esp Urol; 2011; 64(1):51-8. PubMed ID: 21289386
[TBL] [Abstract][Full Text] [Related]
30. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations.
Allaf ME; Varkarakis IM; Bhayani SB; Inagaki T; Kavoussi LR; Solomon SB
Radiology; 2005 Oct; 237(1):366-70. PubMed ID: 16126920
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Zagoria RJ; Hawkins AD; Clark PE; Hall MC; Matlaga BR; Dyer RB; Chen MY
AJR Am J Roentgenol; 2004 Jul; 183(1):201-7. PubMed ID: 15208139
[TBL] [Abstract][Full Text] [Related]
32. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
[TBL] [Abstract][Full Text] [Related]
33. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
34. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses.
Bandi G; Hedican S; Moon T; Lee FT; Nakada SY
J Endourol; 2008 May; 22(5):963-7. PubMed ID: 18643721
[TBL] [Abstract][Full Text] [Related]
35. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
37. Radio-frequency ablation of renal cell carcinoma: early clinical experience.
Gervais DA; McGovern FJ; Wood BJ; Goldberg SN; McDougal WS; Mueller PR
Radiology; 2000 Dec; 217(3):665-72. PubMed ID: 11110926
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?
Giorgio A; Di Sarno A; de Stefano G; Farella N; Scognamiglio U; de Stefano M; Giorgio V
AJR Am J Roentgenol; 2009 Oct; 193(4):948-54. PubMed ID: 19770315
[TBL] [Abstract][Full Text] [Related]
39. [Percutaneous ablation of renal tumors: radiofrequency ablation or cryoablation?].
Buy X; Lang H; Garnon J; Gangi A
J Radiol; 2011 Sep; 92(9):774-88. PubMed ID: 21944236
[TBL] [Abstract][Full Text] [Related]
40. Complications after percutaneous radiofrequency ablation of renal tumors.
Weizer AZ; Raj GV; O'Connell M; Robertson CN; Nelson RC; Polascik TJ
Urology; 2005 Dec; 66(6):1176-80. PubMed ID: 16360436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
